White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

Failure to launch: white paper explores the role of… 5 November 2020
Comprehensive SPC manufacturing waiver key for… 28 May 2018 Medicines for Europe commends the European Commission for proposing an…
Medicines for Europe applauds compromise on SPC… 14 February 2019 Today, the European Council, Parliament and Commission agreed a compromise…
Competition policy essential for access to medicines 28 January 2019 Medicines for Europe welcomes the publication of the European Commission…